Inspiration Healthcare delivers 'strong' H2 performance
By Iain Gilbert
Date: Tuesday 18 Feb 2025
(Sharecast News) - Medical technology manufacturer Inspiration Healthcare said on Tuesday that it had delivered a "strong" H2 performance, with momentum carrying over into the new year.
Inspiration Healthcare said H2 revenues had grown £4.1m half-on-half to £21.3m, pushing FY revenues to £38.3m and helping return the group to profit, with an EBITDA positive performance for the year.
The AIM-listed group also noted that strong sales momentum in Q425 was expected to continue into H126, with FY26 growth underpinned by a recent $6.0m contract win and $4.3m Middle Eastern contract awarded in FY25.
Chairman Roy Davis said: "I am pleased to report a strong second-half performance despite not being able to recognise the partial Middle Eastern contract shipment made in the period. While revenues were, therefore, slightly behind market expectations, we have delivered a positive EBITDA for the full year.
"Our goal is to build on the momentum from the second half of last year to deliver sustained growth in revenue, profit and cash generation."
As of 1125 GMT, Inspiration Healthcare shares had surged 24.37% to 16.79p.
Reporting by Iain Gilbert at Sharecast.com
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN